IPCA asks USFDA to clarify on Hydroxychloroquine risk

Hydroxychloroquine, besides being administered as an anti-malarial drug, is also used as a chronic therapy by patients suffering from auto immune diseases such as RA and Lupus. In the recent months the drug has been used in several countries including India and US in the treatment of critically ill Covid-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2z0oGn5
via IFTTT

0 comments:

Post a Comment